Mary Beth Cicero (3Daughters): 10 Key Things You Must Know

Overview

Mary Beth Cicero is a pioneering leader in the field of women's healthcare with a storied career in pharmaceuticals and biotechnology. As the Co-Founder and CEO of 3Daughters, Cicero has been instrumental in shaping innovative contraceptive technologies aimed at addressing long-standing issues in women's health. Her work includes the development of a novel, frameless, magnetic intrauterine device (IUD), which aims to significantly reduce pain during insertion and improve overall user comfort. As we delve deeper, you will discover intriguing insights into Cicero's career, her groundbreaking contributions to healthcare, and the ambitious goals of her company.

1. Early Life and Education

Mary Beth Cicero was born on November 17, 1953, in Pittsburgh, Pennsylvania. She pursued higher education at Boston College, where she graduated cum laude with a Bachelor of Science degree in Biology in 1975, followed by an MBA in Marketing in 1980. Her academic background laid a strong foundation for her future endeavors in the healthcare industry, providing the skills necessary for both scientific understanding and strategic business management.

2. Founding 3Daughters

Cicero co-founded 3Daughters, a healthcare company, with a mission to revolutionize women's health by developing an innovative IUD. The device is designed to be a frameless, magnetic option that reduces traditional complications associated with IUDs, such as insertion pain and risk of expulsion. Under her leadership, the company has received attention for its cutting-edge approach and dedication to improving women's quality of life through science and technology.

3. A Painless Future for Contraception

At the core of Cicero's vision for 3Daughters is the aim to create a more pleasant contraceptive experience for women worldwide. The new IUD design utilizes a magnetic mechanism that conforms to the body, simplifying usage and potentially alleviating significant discomfort during insertion. This advancement addresses a major pain point in women's contraception, aiming to make this effective birth control method more accessible to women who have previously been deterred by associated discomfort.

4. A Career in Women's Healthcare

With over 40 years in executive roles focused on women's healthcare, Cicero's career highlights include pivotal positions at Serono Labs and Agile Therapeutics. Her extensive experience spans various areas, including contraceptives and fertility treatments. She was notably the Vice President of Business Development for Agile Therapeutics, where she contributed to the development and market strategy for Twirla®, a contraceptive patch.

5. Involvement in the BioLabs Community

Mary Beth Cicero has actively participated in BioLabs' events, an organization dedicated to fostering innovation and entrepreneurship in biotechnology. In 2024, Cicero's company, 3Daughters, stood out at the BioLabs Investor Day in Philadelphia, an acknowledgment she equated to receiving an Academy Award due to the profound recognition and support from industry peers and investors.

6. Educational Contributions

Beyond her corporate responsibilities, Mary Beth Cicero contributes to academia as well. She is involved with the Jie Du Center for Innovation at the University of the Pacific, where she teaches "Marketing Principles and Applications for Pharma Entrepreneurs." This course reflects her commitment to nurturing the next generation of innovators and entrepreneurs in the pharmaceutical field.

7. Leadership at MarketSense Ltd.

Before her tenure at 3Daughters, Cicero was the President of MarketSense Ltd., a healthcare consulting firm. During this period, she engaged with over 100 clients, guiding them through marketing assessments, fundraising, and strategic planning for licensing and partnerships. Her leadership at MarketSense was pivotal in establishing her reputation as a sought-after consultant in the healthcare sector.

8. Recognition and Awards

Throughout her career, Cicero has been recognized for her contributions and leadership in pharmaceuticals and healthcare. She has contributed articles and insights to industry publications like PharmaVOICE, where her expertise on market trends, particularly in drug commercialization, is regularly featured.

9. A Personal Commitment to Innovation

Cicero's career is driven by a personal commitment to innovate within the healthcare industry, particularly focusing on addressing problems that have been overlooked or inadequately addressed, such as the discomfort associated with IUDs. Her work not only emphasizes technological advancements but also raises awareness about women's health issues that require renewed attention and understanding.

10. Future Prospects for 3Daughters

Under Cicero's leadership, 3Daughters is poised to expand its influence in the realm of women's health. With ongoing clinical trials for their innovative IUD, the company aims to broaden its applications, potentially addressing other uterine conditions and contributing significantly to global women's health solutions. The company's success at attracting investor interest suggests a bright future and potential for impact in the sector.

Conclusion

Mary Beth Cicero's journey in the healthcare industry demonstrates a blend of strategic leadership and innovation, particularly in women's health technologies. Her efforts have paved the way for significant advancements in contraception and exemplify the potential to improve women's healthcare worldwide. As 3Daughters continues to grow and pursue its mission, Cicero's vision and leadership assure that the company will remain at the forefront of impactful healthcare solutions.